CompletedNot Applicable

Sonoelastography: Ultrasound Method to Measure Liver Fibrosis

United States180 participantsStarted 2010-02

Plain-language summary

HYPOTHESIS: The investigators hypothesize that sonoelastography (SE) will provide accurate quantitative measurements that can be used to stage liver fibrosis in patients with chronic liver disease. 1. To measure liver stiffness with sonoelastography in adults with suspect diffuse liver disease who will undergo non-focal liver biopsy as part of their routine clinical care 2. To assess the sensitivity and specificity of sonoelastography for the detection and staging of liver fibrosis 3. To evaluate the effect of steatosis and inflammation on the estimation of liver fibrosis using sonoelastography

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients (age 18 or older) * Men or women * Suspected diffuse liver disease * Consent to participate in the study Exclusion Criteria: * Pregnancy * Acute illness/cognitive impairment resulting in inability to cooperate with ultrasound. * Patients that do not consent to ultrasound or sonoelastography.

What they're measuring

Liver Elasticity Value Measured Using Sonoelastography (SE)

Timeframe: Day 1

Trial details

NCT IDNCT01747772

SponsorMassachusetts General Hospital

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2014-02-14

Results submitted2017-03-23

View on ClinicalTrials.gov More Chronic Liver Disease trials